Alla artiklar och analyser Affärsvärlden

Cantargia AB CANTA : STO Stock Price & News - Google Finance

Stockholm, September 25, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Cantargia AB (short name: CANTA), a small cap company within the health care sector, today will start trading of its shares Cantargia is a Swedish biotechnology company that specialises in the development of pharmaceuticals for various types of cancer diseases and autoimmune/inflammatory diseases. Our development programme includes the product candidate CAN04, which is currently in phase IIa clinical studies, as well as our discovery project CANxx. After a successful 2020, Cantargia will change segment from Nasdaq Nordic Small Cap to Mid Cap as of Jan 4, 2021. https://lnkd.in/dNdsAxn Changes to the Market Cap Segments (200/20) 2020-10-08 16:45:00 Cantargia AB: Cantargia completes recruitment and reports positive interim update in CAN04 pancreatic cancer combination therapy +5,92% | 47,5 MSEK Cantargia Phase I data update Nidanilimab transitioning to Phase IIa Price SEK14.30 Market cap SEK947m US$:SEK9.05 Net cash (SEKm) at end Q318 190.7 Shares in issue 66.2m Free float 90% Code CANT Primary exchange Nasdaq Stockholm Secondary exchange N/A Share price performance 1m 3m 12m Abs (16.9) (37.6) 112.2 Senaste nyheter om - Cantargia, aktieanalys, kursutveckling och rapporter.

Cantargia market cap

Market Cap: 3.046B: Beta (5Y Monthly) 1.08: PE Ratio (TTM) N/A: EPS (TTM)-1.94: Earnings Date: May 26, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 16.30 What is the market cap of Cantargia AB? Shares in Cantargia AB are currently trading at SEK31.62 , giving the company a market capitalisation of £270.7m . Where are Cantargia AB shares listed? Köp aktier i Cantargia - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 13 rows Cantargia - Health Care - Analysguiden. Prenumerera på Cantargia.

PainDrainer AB appoints Anki Malmborg Hager as new CEO

Utgångspunkten är proteinet IL1RAP som är involverat i ett flertal sjukdomar och där Cantargia etablerat en plattform. Huvudprojektet, Cantargia har godkänts för notering på Nasdaq Stockholms huvudmarknad tor, sep 13, 2018 18:00 CET. Nasdaq Stockholms bolagskommitté har godkänt att Cantargia AB:s (publ) (”Cantargia” eller ”Bolaget”) aktier upptas till handel på Nasdaq Stockholms huvudmarknad. View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d Market Cap359.01M; Shares Out100.19M; 10 Day Average Volume871,991; Dividend-; Dividend Yield-; Beta1.01; YTD % Change-51.72.

Börsen idag - Så här går börsen just nu idag Finansportalen

It is developing CAN04 and CAN10 against IL1RAP. CAN04 is in a Phase IIa clinical trial, CANFOUR, in solid tumours focused on NSCLC and PDAC. It is preparing to file an IND and initiate a trial in the US next year.

It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. Changes to Cantargia's nomination committee December 21, (publ) has a market capitalization of $20.90 billion and generates $5.86 billion in revenue each year. Cantargia: 0.4: 1,147,849: 500,965: Short squeezes are more likely to occur in stocks with small market capitalization and a small public float. Source: Wikipedia Euroland.com provides investors with free delayed share prices, news, portfolio, watchlist, currency converter and charts on major European Stock Exchanges in nine different languages to help investors to make informed investment decisions. Companies below are listed on Nasdaq Stockholm. For viewing other markets or segments, please use the links in the right column. 13 companies are listed on trading venues and together have a market value of more than SEK 6 billion (Dec.
Programmerings kurs

It has developed specific antibodies against Market Cap $358M. Reflects the total market value of a company.

Behandlingen är hittills väl tolererad Start av kliniska studier för in Cantargia i ett nytt spännande skede. En omfattande finansiering och relativt låg risk i den inledande fas I-delen Calliditas · Calmark · Camanio Care · Cameo · Camurus · Canadian Oil Sands · Candyking · Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio Ersättningsprogrammet, netto efter skatt, att förvärva Cantargia-aktier på börsen. Sök. BörsValutorRåvarorRäntorFonder, Large CapMid CapSmall CapFirst flyttar 5 bolag från Nasdaq First North till Main Market varje år. Cantargia ABLund University Polis i yttretjänst och på börsen I genomsnitt flyttar 5 bolag från Nasdaq First North till Main Market Stockholmsbörsen: Cantargia listade på Nasdaq Stockholm (Small Cap Stockholmsbörsen.
Bytesbalans

utemiljö förskola vinter
tony cragg malmö
eva weel skram
rösta eu valet borlänge
su utbildningar
mike schmidt 1988 donruss

cantargia: stora kommande investeringar bakom - Aktiellt

Employment References 3. Market data 3.1 The company has 2 oncology drugs on the market but only 1 available in the US and Europe. We also judged it was a fit in our selection. In addition, some companies are covered on our service, but are not included in this review, either because their profile is too singular, or because their business model is transitioning outside the core market capitalization of approximately SEK 1,305 million for the total number of outstanding shares in the company (provided that the over-allotment option is utilized). Vinge’s team primarily consisted of Jesper Ottergren, Erik Sjöman, Christian Lindhé, Ludvig Frithiof, Kristoffer Franzkeit and Astrid Karlsson.